{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:29:54Z","timestamp":1786364994211,"version":"build-2736575974"},"reference-count":55,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd016379","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:46:51Z","timestamp":1786362411000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological treatment for uterine fibroids"],"prefix":"10.1002","volume":"2026","author":[{"given":"Akanksha","family":"Garg","sequence":"additional","affiliation":[{"name":"Obstetrics, Gynecology, and Reproductive Sciences; Yale School of Medicine; New Haven Connecticut USA"},{"name":"Department of Metabolism, Digestion and Reproduction; Imperial College London; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lacey","family":"Brennan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology; University of Calgary; Calgary, Alberta Canada"},{"name":"Department of Obstetrics and Gynecology; Peter Lougheed Centre; Calgary, Alberta Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Gustavo O","family":"Brito","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics; University of S\u00e3o Paulo, Ribeir\u00e3o Preto Medical School; Ribeir\u00e3o Preto Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Nagels","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology; University of Auckland; Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3154-744X","authenticated-orcid":false,"given":"Angela","family":"Beros","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics; University of Auckland; Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD016379-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: a systematic review","volume":"124","author":"Stewart","year":"2017","journal-title":"BJOG"},{"issue":"1","key":"10.1002\/14651858.CD016379-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD016379-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ijgo.2015.04.051","article-title":"Prevalence, morbidity, and current medical management of uterine leiomyomas","volume":"131","author":"Drayer","year":"2015","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD016379-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ogc.2005.12.002","article-title":"Clinical features of myomas","volume":"33","author":"Bukulmez","year":"2006","journal-title":"Obstetrics and Gynecology Clinics"},{"issue":"5","key":"10.1002\/14651858.CD016379-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/humupd\/4.5.520","article-title":"The ultrastructure of fibromyomatous myometrium and its relationship to infertility","volume":"4","author":"Richards","year":"1998","journal-title":"Human Reproduction Update"},{"issue":"351","key":"10.1002\/14651858.CD016379-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"h4887","DOI":"10.1136\/bmj.h4887","article-title":"Fibroids: diagnosis and management","volume":"13","author":"Lumsden","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD016379-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ijgo.2010.11.011","article-title":"FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"Munro","year":"2011","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD016379-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/ijgo.12666","article-title":"The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions","volume":"143","author":"Munro","year":"2018","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"4","key":"10.1002\/14651858.CD016379-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1210\/endrev\/bnab039","article-title":"Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment","volume":"43","author":"Yang","year":"2022","journal-title":"Endocrine Reviews"},{"issue":"6","key":"10.1002\/14651858.CD016379-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1093\/humupd\/6.6.614","article-title":"Fibroids, infertility and pregnancy wastage","volume":"6","author":"Bajekal","year":"2000","journal-title":"Human Reproduction Update"},{"key":"10.1002\/14651858.CD016379-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"173184","DOI":"10.1155\/2013\/173184","article-title":"Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction","volume":"2013","author":"Ciavattini","year":"2013","journal-title":"Obstetrics and Gynecology International"},{"issue":"4","key":"10.1002\/14651858.CD016379-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bpobgyn.2008.04.002","article-title":"Incidence, aetiology and epidemiology of uterine fibroids","volume":"22","author":"Okolo","year":"2008","journal-title":"Best Practice & Research Clinical Obstetrics & Gynaecology"},{"issue":"6","key":"10.1002\/14651858.CD016379-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1210\/jcem.80.6.7775635","article-title":"Estrogen receptor gene expression in human uterine leiomyomata","volume":"80","author":"Brandon","year":"1995","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD016379-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.advms.2024.01.001","article-title":"Progesterone signaling in uterine leiomyoma biology: implications for potential targeted therapy","volume":"69","author":"Szucio","year":"2024","journal-title":"Advances in Medical Sciences"},{"issue":"4","key":"10.1002\/14651858.CD016379-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.bpobgyn.2008.01.007","article-title":"Asymptomatic uterine fibroids","volume":"22","author":"Divakar","year":"2008","journal-title":"Best Practice & Research Clinical Obstetrics & Gynaecology"},{"issue":"18","key":"10.1002\/14651858.CD016379-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s40265-023-01958-6","article-title":"Current and emerging treatment options for uterine fibroids","volume":"83","author":"Ali","year":"2023","journal-title":"Drugs"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD016379-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.4103\/2141-9248.141955","article-title":"Pharmacological treatment of uterine fibroids","volume":"4","author":"Moroni","year":"2014","journal-title":"Annals of Medical and Health Sciences Research"},{"issue":"1","key":"10.1002\/14651858.CD016379-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.fertnstert.2024.04.041","article-title":"The modern management of uterine fibroids-related abnormal uterine bleeding","volume":"122","author":"Vannuccini","year":"2024","journal-title":"Fertility and Sterility"},{"issue":"16","key":"10.1002\/14651858.CD016379-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1080\/14656566.2023.2248890","article-title":"GnRH agonists and antagonists in therapy of symptomatic uterine fibroids \u2013 current roles and future perspectives","volume":"24","author":"Ciebiera","year":"2023","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"30","key":"10.1002\/14651858.CD016379-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"e943614","DOI":"10.12659\/MSM.943614","article-title":"Advancements and emerging therapies in the medical management of uterine fibroids: a comprehensive scoping review","volume":"5","author":"Krzy\u017canowski","year":"2024","journal-title":"Medical Science Monitor"},{"issue":"3","key":"10.1002\/14651858.CD016379-BIB0021|cit21","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010854.pub2","article-title":"Add-back therapy with GnRH analogues for uterine fibroids","author":"Moroni","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD016379-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.jacr.2020.03.018","article-title":"Invasive procedural treatments for symptomatic uterine fibroids: a cost analysis","volume":"17","author":"Cronan","year":"2020","journal-title":"Journal of the American College of Radiology"},{"issue":"4","key":"10.1002\/14651858.CD016379-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1089\/gyn.2022.0127","article-title":"Myomectomy benefits, risks, long-term outcomes, and effects on fertility and pregnancy outcomes: a literature review","volume":"39","author":"Gnanachandran","year":"2023","journal-title":"Journal of Gynecologic Surgery"},{"issue":"3","key":"10.1002\/14651858.CD016379-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.5603\/GP.a2021.0202","article-title":"Minimally invasive treatment options for uterine fibroids \u2014 state-of-the art 2021","volume":"93","author":"Krzyzanowski","year":"2022","journal-title":"Ginekologia Polska"},{"key":"10.1002\/14651858.CD016379-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12905-022-01627-y","article-title":"Comparison of two invasive non-surgical treatment options for uterine myomas: uterine artery embolization and magnetic resonance guided high intensity focused ultrasound\u2014systematic review","volume":"22","author":"Yerezhepbayeva","year":"2022","journal-title":"BMC Women's Health"},{"issue":"12","key":"10.1002\/14651858.CD016379-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1007\/s43032-024-01727-0","article-title":"The annual economic burden of uterine fibroids in the United States (2010 versus 2022): a comparative cost-analysis","volume":"31","author":"Hazimeh","year":"2024","journal-title":"Reproductive Sciences"},{"issue":"4","key":"10.1002\/14651858.CD016379-BIB0027|cit27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000547.pub3","article-title":"Preoperative medical therapy before surgery for uterine fibroids","author":"Puscasiu","year":"2025","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD016379-BIB0028|cit28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015650","article-title":"Surgery and minimally invasive treatments for uterine fibroids","author":"Krishnan","year":"2024","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD016379-BIB0029|cit29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009505.pub2","article-title":"Aromatase inhibitors for uterine fibroids","author":"Song","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD016379-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007687.pub2","article-title":"Mifepristone for uterine fibroids","author":"Tristan","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD016379-BIB0031|cit31","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008994.pub2","article-title":"Progestogens or progestogen-releasing intrauterine systems for uterine fibroids","author":"Sangkomkamhang","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD016379-BIB0032|cit32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005287.pub4","article-title":"Selective estrogen receptor modulators (SERMs) for uterine leiomyomas","author":"Deng","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD016379-BIB0033|cit33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010770.pub2","article-title":"Selective progesterone receptor modulators (SPRMs) for uterine fibroids","author":"Murji","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD016379-BIB0034|cit34","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012846","article-title":"GnRH agonists for uterine fibroids","author":"Hodgson","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD016379-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009737","article-title":"Progestogen only versus combined oral contraceptive pills for fibroid related heavy menstrual bleeding","author":"Eke","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD016379-BIB0036|cit36","unstructured":"Higgins JP Lasserson T Thomas J Flemyng E Churchill R Methodological expectations of Cochrane intervention reviews. Cochrane: London, Version August 2023 Available from https:\/\/community.cochrane.org\/mecir-manual"},{"key":"10.1002\/14651858.CD016379-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016379-BIB0038|cit38","unstructured":"World Health Organization Women of reproductive age (15-49 years) population (thousands) https:\/\/www.who.int\/data\/gho\/indicator-metadata-registry\/imr-details\/women-of-reproductive-age-(15-49-years)-population-(thousands)"},{"issue":"4","key":"10.1002\/14651858.CD016379-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"541","DOI":"10.4300\/JGME-5-4-18","article-title":"Analyzing and interpreting data from Likert-type scales","volume":"5","author":"Sullivan","year":"2013","journal-title":"Journal of Graduate Medical Education"},{"issue":"2","key":"10.1002\/14651858.CD016379-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/s0029-7844(01)01702-1","article-title":"The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata","volume":"99","author":"Spies","year":"2002","journal-title":"Obstetrics & Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD016379-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","article-title":"EuroQoL: the current state of play","volume":"37","author":"Brooks","year":"1996","journal-title":"Health Policy"},{"issue":"6","key":"10.1002\/14651858.CD016379-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware Jr","year":"1992","journal-title":"Medical Care"},{"key":"10.1002\/14651858.CD016379-BIB0043|cit43","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Chapter 4: Searching for and selecting studies (chapter last updated September 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current"},{"key":"10.1002\/14651858.CD016379-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41073-023-00130-8","article-title":"Checklist to assess Trustworthiness in RAndomised Controlled Trials (TRACT checklist): concept proposal and pilot","volume":"8","author":"Mol","year":"2023","journal-title":"Research Integrity and Peer Review"},{"key":"10.1002\/14651858.CD016379-BIB0045|cit45","doi-asserted-by":"crossref","unstructured":"Wilkinson J Heal C Flemyng E Antoniou GA Aburrow T Alfirevic Z INSPECT-SR: a tool for assessing trustworthiness of randomised controlled trials medRxiv 2025.09.03.25334905 10.1101\/2025.09.03.25334905","DOI":"10.1101\/2025.09.03.25334905"},{"key":"10.1002\/14651858.CD016379-BIB0046|cit46","unstructured":"Covidence Veritas Health Innovation 2025"},{"key":"10.1002\/14651858.CD016379-BIB0047|cit47","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from https:\/\/training.cochrane.org\/handbook\/archive\/v5.1\/"},{"key":"10.1002\/14651858.CD016379-BIB0048|cit48","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing evidence in a meta-analysis (chapter last updated August 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current"},{"key":"10.1002\/14651858.CD016379-BIB0049|cit49","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2026"},{"key":"10.1002\/14651858.CD016379-BIB0050|cit50","unstructured":"McKenzie JE Brennan SE Chapter 12: Synthesizing and presenting findings using other methods [last updated October 2019]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current"},{"issue":"4","key":"10.1002\/14651858.CD016379-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"e244165","DOI":"10.1001\/jamanetworkopen.2024.4165","article-title":"The intersection of structural racism and health services research in characterizing the epidemiology of uterine fibroids","volume":"7","author":"Roberson","year":"2024","journal-title":"JAMA Network Open"},{"issue":"3","key":"10.1002\/14651858.CD016379-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.whi.2021.01.001","article-title":"Black women's psychosocial experiences with seeking surgical treatment for uterine fibroids: implications for clinical practice","volume":"31","author":"VanNoy","year":"2021","journal-title":"Women's Health Issues"},{"key":"10.1002\/14651858.CD016379-BIB0053|cit53","unstructured":"Welch VA Petkovic J Jull J Hartling L Klassen T Kristjansson E Chapter 16: Equity and specific populations (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current"},{"key":"10.1002\/14651858.CD016379-BIB0054|cit54","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2026"},{"key":"10.1002\/14651858.CD016379-BIB0055|cit55","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: completing 'Summary of findings' tables and grading the certainty of evidence (chapter last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:46:54Z","timestamp":1786362414000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD016379"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":55,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd016379","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]}}}